L'AIAC et ISDE publient le plus récent rapport sur l'état de l'industrie aérospatiale canadienne
July 11, 2024 14:00 ET
|
L'Association des industries aérospatiales du Canada
OTTAWA, 11 juill. 2024 (GLOBE NEWSWIRE) -- Des données récemment publiées révèlent que l'industrie aérospatiale canadienne montre des signes de reprise économique et continue d'être un moteur...
AIAC & ISED Release Latest State Of Canada’s Aerospace Industry Report
July 11, 2024 14:00 ET
|
Aerospace Industries Association of Canada (AIAC)
Aerospace Industries Association of Canada, in partnership with ISED, release the latest State of Canada’s Aerospace Industry Report.
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
July 10, 2024 08:05 ET
|
Tevogen Bio Inc
Dr. Flomenberg and Dr. Grosso are leading experts in T cell biology and its clinical applicationsTevogen’s ExacTcell™ platform is designed to address current cost, and patient accessibility...
Resonac Announces New US-JOINT Consortium; Ten Partners to Collaborate on Next-Generation Semiconductor Packaging in Silicon Valley
July 08, 2024 08:07 ET
|
Resonac Holdings Corporation
Resonac Corporation today unveiled a new consortium of ten partners, called “US-JOINT,” for its semiconductor back-end process R&D in Silicon Valley.
CBIH Charts Path to Future Leadership in Cannabis Medicine
July 08, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
June 26, 2024 19:05 ET
|
Nxera Pharma
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone under its multi-target discovery collaboration...
ABB investing $35 million in new U.K. earthing and lightning protection factory
June 25, 2024 07:30 ET
|
ABB Electrification
ZURICH, SWITZERLAND, June 25, 2024 (GLOBE NEWSWIRE) -- Technologically advanced factory will increase production of Furse® earthing and lightning protection solutions, used in more than 20...
Genetec expands global presence with new R&D hubs and Experience Centers to support rapid growth
May 29, 2024 09:00 ET
|
Genetec, Inc.
Montreal, QC, Canada, May 29, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions,...
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
May 09, 2024 08:00 ET
|
Optimi Health Corp.
Export Permit granted: Optimi's Shipment of MDMA active pharmaceutical ingredient (API) to Israel marks the Company’s first international export